Hikal Ltd. (HIKAL) Share Price Rises 10.79% as Market Cap Reaches Rs 2,448.14 Cr
- September 3, 2026
- Posted by: Harsh Piplani
- Category: News
Hikal Ltd. Share Price is in focus today after the stock rose 10.79% to Rs 222.75, taking its market capitalisation to Rs 2,448.14 Cr. According to latest Univest data, the move has pushed Hikal Ltd. into the list of stocks in news on the Indian stock market, even though the verified data does not establish a company-specific catalyst. The share price gain is notable because it came alongside a broad intraday move from Rs 200.10 to Rs 223.90, with the stock last traded near the day’s high. For investors tracking Hikal Ltd. Share Price Today, the key question is not only what changed in price action, but also how the company’s valuation and healthcare sector context compare with peers. Univest analysis points to a stock that is attracting attention on price action rather than any confirmed fresh announcement.
Hikal Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 222.75 |
| Previous Close | Rs 201.05 |
| Today's Move | Rs 21.7 (+10.79%) |
| Open | Rs 200.1 |
| High | Rs 223.9 |
| Low | Rs 200.1 |
| Turnover | Rs 1.09 crore |
| Market Capitalisation | Rs 2,448.14 crore |
| Market Cap Category | Small Cap |
Hikal Ltd. (HIKAL) rose to Rs 222.75 from the previous close of Rs 201.05, a move of Rs 21.7 or 10.79%. The stock opened at Rs 200.1, reached a high of Rs 223.9, recorded a low of Rs 200.1.
Hikal Ltd. Share Price Today reflects a sharp same-day gain of Rs 21.70 over the previous close of Rs 201.05. The stock opened at Rs 200.10, matched the low at Rs 200.10, and touched a high of Rs 223.90 before trading at Rs 222.75. That pattern shows firm buying interest after the open and places Hikal Ltd. among the top gainers today in the broader share market today conversation. The latest Univest figures confirm a clean price rise, but they do not establish a company-specific trigger. For readers following Hikal Ltd. Stock News, the important point is that the move is being driven by price action first, with the market now reassessing the stock’s position in the near term. Hikal Ltd. Share Price Live will remain relevant as traders watch whether this momentum is sustained in the next market update.
Hikal Ltd. (HIKAL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,448.14 crore |
| P/B Ratio | 2.08x |
| ROE | 7.41% |
| ROCE | 9.88% |
| EPS | Rs -2.74 |
| Book Value Per Share | Rs 96.62 |
| Dividend Yield | 0.3% |
Hikal Ltd. (HIKAL) fundamental metrics show P/B 2.08x, ROE 7.41%, ROCE 9.88%. These figures provide context only and are not a buy or sell signal.
Hikal Ltd. has a market capitalisation of Rs 2448.14 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 2.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.41% and ROCE of 9.88%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.74, book value per share of Rs 96.62, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.97x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 31.97x |
| Benchmark Average P/E | 48.6x |
| Benchmark P/E Range | 3.49x to 648.54x |
| Company P/B Ratio | 2.08x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 7.41% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 9.88% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 2,448.14 crore |
| Benchmark Median Market Cap | Rs 727.27 crore |
Hikal Ltd. (HIKAL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Hikal Ltd. (HIKAL) has a ROE of 7.41%, which is below the benchmark median of 11.79%, a difference of -37.15%. Hikal Ltd. (HIKAL) has a ROCE of 9.88%, which is below the benchmark median of 13.63%, a difference of -27.51%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,179.62 | 38.34 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,301.95 | 83.79 | 13.88 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,622.52 | 87.28 | 21.21 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,114.43 | 25.44 | 4.26 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.87 | 3.25 | 11.83 | 16 |
Its ROE of 7.41% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 9.88% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Hikal Ltd. (HIKAL) has a market capitalisation of Rs 2,448.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Hikal Ltd.
- Hikal Ltd. Share Price rose 10.79% to Rs 222.75, making it one of the notable Stocks Rising Today.
- The stock moved from Rs 200.10 to Rs 223.90 intraday, which keeps price action in focus on the Share Market Today.
- Hikal Ltd. Market Cap of Rs 2,448.14 Cr places it above the same-industry median, giving the move added visibility.
- Its P/B of 2.08 is below the industry median, so valuation remains part of the Hikal Ltd. Fundamental Analysis story.
- The stock’s ROE of 7.41% and ROCE of 9.88% trail industry medians, so Univest investors may watch profitability context closely.
About Hikal Ltd.
Hikal Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for serving pharmaceutical and allied end markets, which places Hikal Ltd. Stock News within a sector that often draws attention from both domestic and global investors. For readers tracking Hikal Ltd. Share Price, the company’s position in the industry matters because pricing often reflects a mix of business quality, earnings trends and sector sentiment. The latest Univest figures show a company with a market cap of Rs 2,448.14 Cr, book value of Rs 96.62 and dividend yield of 0.3%. Its EPS of -2.74 also indicates that the earnings base needs careful monitoring. Hikal Ltd. Share Price Today is therefore not just a price story; it is also a reminder that investors often compare current momentum with financial structure and industry context before they follow a stock further.
Frequently Asked Questions
Why is Hikal Ltd. Share Price rising today?
Ans. Hikal Ltd. Share Price rose 10.79% to Rs 222.75 today. The latest Univest data confirms the price move, but it does not establish a company-specific catalyst behind the gain.
What is Hikal Ltd. Share Price Today?
Ans. Hikal Ltd. Share Price Today is Rs 222.75. The stock moved up from the previous close of Rs 201.05 and touched a high of Rs 223.90 during the current trading session.
How much did Hikal Ltd. stock gain today?
Ans. Hikal Ltd. stock gained Rs 21.70, which translates into a 10.79% rise. That makes it a notable share price gain in the healthcare space and places it among today’s active movers.
What is Hikal Ltd. market capitalisation now?
Ans. Hikal Ltd. market capitalisation stands at Rs 2,448.14 Cr. That size places it above the same-industry median in the healthcare benchmark, though well below the largest listed peers.
Is Hikal Ltd. expensive compared with peers?
Ans. Hikal Ltd.’s P/B ratio of 2.08 is below the same-industry median of 2.87 and below several peers, including Cipla, Zydus Lifesciences and Sun Pharma. The valuation view is therefore restrained on that measure.
How do Hikal Ltd. fundamentals look?
Ans. Hikal Ltd. shows book value of Rs 96.62, dividend yield of 0.3%, ROE of 7.41% and ROCE of 9.88%. EPS of -2.74 indicates that earnings per share remain under pressure.
Which sector does Hikal Ltd. belong to?
Ans. Hikal Ltd. belongs to Healthcare and the Pharmaceuticals & Drugs industry. That sector context matters because peer valuation, return ratios and market-cap comparison can differ sharply across listed drug companies.
Should investors track Hikal Ltd. Share Price on Univest?
Ans. Investors tracking Hikal Ltd. Share Price can use Univest for live pricing, market cap, sector comparison, financial ratios and latest company news. It helps place the day’s price rise in a broader market context.
Track Hikal Ltd. Share Price on Univest
Use Hikal Ltd. (HIKAL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Hikal Ltd. Share Price on Univest for live price updates, share price rise coverage, fundamental ratios, sector comparisons, market cap, 52-week levels and broader market insights. Univest brings Hikal Ltd. Share Price Today, Hikal Ltd. Latest News and Hikal Ltd. Stock Analysis together in one place so readers can follow price action and financial context without switching screens.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
